Perioperative cardioprotection

F1000Prime Reports

Volumn 5, Issue , 2013, Pages

  Leung, May K M ^a   Irwin, Michael G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BISOPROLOL; DEXMEDETOMIDINE; GLUCOSE; METOPROLOL; NITROUS OXIDE; PROPOFOL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; EPIDURAL ANESTHESIA; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART PROTECTION; HUMAN; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; RISK ASSESSMENT;

EID: 84876774488     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P5-7     Document Type: Article

References (53)

1. Bainbridge D, Martin J, Arango M, Cheng D: Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet 2012, 380: 1075-81.
2. Merry AF, Webster CS: Has anesthesia care become safer and is anesthesia-related mortality decreasing? F1000 Med Rep 2009, 1.
3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, et al.: Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125: 188-97.
4. Abrams J: Clinical practice. Chronic stable angina. N Engl J Med 2005, 352: 2524-33. (Pubitemid 41007868)
5. Lucreziotti S, Carletti F, Santaguida G, Fiorentini C: Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention. Heart Int 2006, 2: 82.
6. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, et al.: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:e418-99.
7. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100: 1043-9. (Pubitemid 29416229)
8. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF: 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2009, 54:e13-e118.
9. Chassot P, Delabays A, Spahn DR: Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007, 99: 316-28. (Pubitemid 47321534)
10. Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM: Clopidogrel and bleeding after general surgery procedures. Am Surg 2008, 74: 721-5.
11. Vane JR, Botting RM: The mechanism of action of aspirin. Thromb Res 2003, 110: 255-8. (Pubitemid 37329821)
12. Hennekens CH: Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions. Curr Atheroscler Rep 2007, 9: 409-16. (Pubitemid 350104240)
13. Burger W, Chemnitius J, Kneissl GD, Rücker G: Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005, 257: 399-414. (Pubitemid 40604544)
14. Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I: Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg 2012, 255: 811-9.
15. Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE: Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000, 35: 1288-94. (Pubitemid 30206904)
16. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, Hanson AC, Schroeder DR, Oliver WC, Holmes DR, Rihal CS: Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008, 109: 588-95.
17. Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HHH, Hoeks SE, Poldermans D: Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007, 49: 122-4. (Pubitemid 46026891)
18. Rhee SJ, Yun KH, Lee SR, Chae J, Nam C, Jun D, Jeong J: Drugeluting stent thrombosis during perioperative period. Int Heart J 2008, 49: 135-42. (Pubitemid 351907733)
19. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS: Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008, 109: 596-604.
20. McGettigan P, Henry D: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006, 296: 1633-44. (Pubitemid 44511610)
21. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005, 352: 1081-91. (Pubitemid 40365349)
22. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL: betaadrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000, 101: 2103-9. (Pubitemid 30233176)
23. Yeager MP, Fillinger MP, Hettleman BD, Hartman GS: Perioperative beta-blockade and late cardiac outcomes: a complementary hypothesis. J Cardiothorac Vasc Anesth 2005, 19: 237-41. (Pubitemid 40544458)
24. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371: 1839-47.
25. Redelmeier D, Scales D, Kopp A: Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 2005, 331: 932.
26. Poldermans D, Bax JJ, Boersma E, de Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid J, Sellevold OFM, Sicari R, van den Berghe G, Vermassen F: Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009, 30: 2769-812.
27. Pedersen TR: Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Am J Cardiovasc Drugs 2010, 10(Suppl 1): 10-7.
28. Beri A, Sural N, Mahajan SB: Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs 2009, 9: 361-70.
29. Durazzo AES, Machado FS, Ikeoka DT, de Bernoche C, Monachini MC, Puech-Leão P, Caramelli B: Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004, 39: 967-75; discussion 975-6.
30. Ward RP, Leeper NJ, Kirkpatrick JN, Lang RM, Sorrentino MJ, Williams KA: The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 2005, 104: 264-8. (Pubitemid 41379059)
31. Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O'Donnell MJ, Moscucci M: Statin therapy reduces contrastinduced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 2005, 118: 843-9. (Pubitemid 41097461)
32. Biccard BM, Sear JW, Foëx P: The pharmaco-economics of perioperative statin therapy. Anaesthesia 2005, 60: 1059-63.
33. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74: 1124-36. (Pubitemid 17174962)
34. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P: Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993, 87: 893-9. (Pubitemid 23070821)
35. Riess ML, Stowe DF, Warltier DC: Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol 2004, 286:H1603-7. (Pubitemid 38525444)
36. Frädorf J, Huhn R, Weber NC, Ebel D, Wingert N, Preckel B, Toma O, Schlack W, Hollmann MW: Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo. Anesthesiology 2010, 113: 1289-98.
37. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamidesensitive mechanism in the rat heart. Circ Res 1996, 78: 1100-4.
38. Greco M, Landoni G, Biondi-Zoccai G, Cabrini L, Ruggeri L, Pasculli N, Giacchi V, Sayeg J, Greco T, Zangrillo A: Remifentanil in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2012, 26: 110-6.
39. Xia Z, Huang Z, Ansley DM: Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006, 103: 527-32. (Pubitemid 44542898)
40. Huang Z, Zhong X, Irwin MG, Ji S, Wong GT, Liu Y, Xia Z, Finegan BA, Xia Z: Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci 2011, 121: 57-69.
41. Wang H, Luo M, Li C, Wang G: Propofol post-conditioning induced long-term neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia/reperfusion. J Neurochem 2011, 119: 210-9.
42. Myles PS, Leslie K, Chan MTV, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E: Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 2007, 107: 221-31. (Pubitemid 47196484)
43. Leslie K, Myles PS, Chan MTV, Forbes A, Paech MJ, Peyton P, Silbert BS, Williamson E: Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth Analg 2011, 112: 387-93.
44. Ibacache M, Sanchez G, Pedrozo Z, Galvez F, Humeres C, Echevarria G, Duaso J, Hassi M, Garcia L, Díaz-Araya G, Lavandero S: Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochim Biophys Acta 2012, 1822: 537-45.
45. Zhu Y,Wang C, Chen L,Qian L,Ma L, Yu J, Zhu M,Wen C, Yu L, YanM: Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013, 1494: 1-8.
46. Gu J, Sun P, Zhao H,Watts HR, Sanders RD, TerrandoN, Xia P,Maze M, Ma D: Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011, 15:R153.
47. Aantaa R, Jaakola ML, Kallio A, Kanto J: Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology 1997, 86: 1055-60. (Pubitemid 27208902)
48. Biccard BM, Goga S, de Beurs J: Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia 2008, 63: 4-14. (Pubitemid 350233216)
49. Gauss A, Jahn SK, Eberhart LHJ, Stahl W, Rockemann M, Georgieff M, Wagner F, Meierhenrich R: Kardioprotektion durch thorakale Periduralanästhesie? Metaanalyse. Anaesthesist 2011, 60: 950-62.
50. Rigg JRA, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW, Collins KS: Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002, 359: 1276-82. (Pubitemid 34310632)
51. Hanninen M, McAlister FA, Bakal JA, van Diepen S, Ezekowitz JA: Neither Diabetes nor Glucose-Lowering Drugs Are Associated With Mortality After Noncardiac Surgery in Patients With Coronary Artery Disease or Heart Failure. Can J Cardiol 2012.
52. Inzucchi SE, Siegel MD: Glucose control in the ICU-how tight is too tight? N Engl J Med 2009, 360: 1346-9.
53. Drenger B, Fontes ML, Miao Y, Mathew JP, Gozal Y, Aronson S, Dietzel C, Mangano DT: Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation 2012, 126: 261-9.